Vanta Bioscience Ltd IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 717,000 (47%) | — | ₹359 Cr |
| Retail | — | 717,000 (47%) | — | ₹359 Cr |
| Market Maker | — | 78,000 (5%) | — | ₹4 Cr |
| Σ Total | — | 1,512,000 (100%) | — | ₹7,560 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 3,000 | ₹150,000 |
| Retail (Max) | 13 | 39,000 | ₹1,950,000 |
| S-HNI (Min) | 14 | 42,000 | ₹2,100,000 |
| B-HNI (Min) | 67 | 201,000 | ₹10,050,000 |
Financial Statements Amount in ₹ Lakhs
| Metric | 31-Mar-2017 |
|---|---|
| Total Assets | 1,375 |
| Reserves & Surplus | 365 |
| Total Borrowing | 751 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Augmenting additional working capital requirements – 6.79
- General Corporate Purposes – 0.27
Company Overview
Incorporated in 1995, Vanta Bioscience Ltd (VBL) is a preclinical contract research company which offers safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition they also provides risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachable including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBL also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers. Their services include toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation.
One of the major services of VBL is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms. The relationship between dose and its effects on the exposed organism is of high significance in toxicology. Toxicology and safety assessment are sometimes used interchangeably and considered as synonymous.
Vanta Bioscience based in Des Moines, Iowa with additional offices in Brussels, Belgium; and West Des Moines, Iowa. It has a toxicology research facility in Chennai, India.